HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 296/6/R1716    most recent 00075.2009v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (2) Citing Articles via Google Scholar Google Scholar Articles by Donahue, R. N. Articles by Zagon, I. S. Search for Related Content PubMed PubMed Citation Articles by Donahue, R. N. Articles by Zagon, I. S.

RECEPTORS AND SIGNALING PATHWAYS

Cell proliferation of human ovarian cancer is regulated by the opioid growth factor-opioid growth factor receptor axis

Department of Neural and Behavioral Sciences, The Pennsylvania State University College of Medicine, Hershey, Pennsylvania

Submitted 3 February 2009 ; accepted in final form 10 March 2009

Ovarian cancer is the leading cause of death from gynecological malignancies. Understanding the biology of these tumors, as well as treatment modalities, has been challenging. The opioid growth factor (OGF; [Met⁵]-enkephalin) and the OGF receptor (OGFr) form an endogenous growth-regulating pathway in homeostasis and neoplasia. In this investigation, we examined the relationship of the OGF-OGFr axis to ovarian cancer, and defined its presence, function, and mechanisms. Using OVCAR-3 and SKOV-3 ovarian cancer cell lines, we found that OGF and OGFr were present and functional. Exogenous OGF was observed to have a dose-dependent, serum-independent, reversible, and receptor-mediated inhibitory action on cell proliferation that was dependent on RNA and protein synthesis. The repressive effect of OGF on cell proliferation also was observed in SW626, CAOV-3, and HEY ovarian cancer cell lines. Endogenous OGF was found to be constitutively produced and tonically active on cell replicative activities, with neutralization of this peptide accelerating cell proliferation. Silencing of OGFr using siRNA technology stimulated cell replication, documenting its integral role. The mechanism of OGF-OGFr action on DNA synthesis was related to the cyclin-dependent kinase inhibitory pathway because knockdown of p16 or p21 in OVCAR-3 cells, and p21 in SKOV-3 cells, eliminated OGF's inhibitory effect on growth. These data are the first to report that the OGF-OGFr system is a native biological regulator of cell proliferation in human ovarian cancer. This information will be important in designing treatment strategies for this deadly disease.

ovarian cancer; cell proliferation; tissue culture; siRNA; cyclin-dependent kinase inhibitor

This article has been cited by other articles:

				I. S. Zagon, K. A. Rahn, A. P. Turel, and P. J. McLaughlin Endogenous Opioids Regulate Expression of Experimental Autoimmune Encephalomyelitis: A New Paradigm for the Treatment of Multiple Sclerosis Experimental Biology and Medicine, November 1, 2009; 234(11): 1383 - 1392. [Abstract] [Full Text] [PDF]

				I. S. Zagon, R. N. Donahue, and P. J. McLaughlin Opioid growth factor-opioid growth factor receptor axis is a physiological determinant of cell proliferation in diverse human cancers Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2009; 297(4): R1154 - R1161. [Abstract] [Full Text] [PDF]

				F. Cheng, P. J. McLaughlin, W. A. Banks, and I. S. Zagon Passive diffusion of naltrexone into human and animal cells and upregulation of cell proliferation Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2009; 297(3): R844 - R852. [Abstract] [Full Text] [PDF]